7. Conclusions

After more than fifteen years, the often lively and contradictory scientific reflections and discussions carried out by international and national multidisciplinary groups have led to the adoption of a comparative methodological approach for assessing the safety of GM plants.

No publication whose protocol and/or results are recognized by the scientific community has been able to provide proof of a proven risk from GMPs that are the subject of an application for authorization to grow or market. The assessments carried out allow us to conclude that these GMPs pose no more health problems than the conventional foods with which they can be compared. A fairly comprehensive presentation of the data obtained can be found in the EFSA report .

Questions remain, however, concerning the safety assessment not only of GMPs, but of all...